Immunoprofile of Hodgkin's lymphoma in India.

  title={Immunoprofile of Hodgkin's lymphoma in India.},
  author={Nikhil V Patkar and Jawahar L Mehta and Bijal Kulkarni and Rashmi Pande and Sadhna Advani and Anita M. Borges},
  journal={Indian journal of cancer},
  volume={45 2},
AIMS AND BACKGROUND The immunoprofile of the Reed Sternberg cell with respect to immunoreactivity for CD20 and lack of CD15 has been described as a poor prognostic factor. Large scale studies analyzing the immunoprofile of Hodgkin's lymphoma (HL) from India are lacking. The aim of this study was to obtain baseline information on relative frequencies and immunoprofiles of the two major types of HL and comparing reports from developed and developing countries. MATERIALS AND METHODS 451 cases of… CONTINUE READING


Publications referenced by this paper.

immunotherapy of Hodgkin’s lymphoma

P Correa, GT O’Conor
  • 2005

year report of the population based cancer registries 1999-2000. Bangalore: National Cancer Registry Program

A Tzankov, J Krugmann, +3 authors S. Dirnhofer
  • Indian Council of Medical Research;
  • 2005

An overview of the current clinical use 16 . of the anti - CD 20 monoclonal antibody rituximab

A Younes, J Romaguera, F Hagemeister, P McLaughlin, P Fiumara
  • Ann Oncol
  • 2004

A pilot study of rituximab in patients with recurrent, classic Hodgkin disease

MA, P Fiumara
  • Cancer
  • 2003

Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2003